Yi Larson, EVP & Chief Financial Officer at Turning Point Therapeutics, Inc. (TPTX), sold 58,400 shares at $129.80 ($7.4M) on 2021-02-02, disclosed to the SEC on 2021-02-02.
Open-market sale of $7.4M TPTX by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $122.94 | 4,783 | $588K | 7.9% |
| 2 | $122.94 | 4,783 | $588K | 7.9% |
| 3 | $123.70 | 8,576 | $1.1M | 14.3% |
| 4 | $123.70 | 8,576 | $1.1M | 14.3% |
| 5 | $124.60 | 2,143 | $267K | 3.6% |
| 6 | $124.60 | 2,143 |
| $267K |
| 3.6% |
| 7 | $126.07 | 200 | $25K | 0.3% |
| 8 | $127.58 | 1,000 | $128K | 1.7% |
| 9 | $128.41 | 400 | $51K | 0.7% |
| 10 | $129.80 | 4,574 | $594K | 8.0% |
| 11 | $129.80 | 4,574 | $594K | 8.0% |
| 12 | $130.58 | 7,267 | $949K | 12.8% |
| 13 | $130.58 | 7,267 | $949K | 12.8% |
| 14 | $131.73 | 1,057 | $139K | 1.9% |
| 15 | $131.73 | 1,057 | $139K | 1.9% |
| Total | $126.71 avg | 58,400 | $7.4M | 100% |